JP2005522454A5 - - Google Patents

Download PDF

Info

Publication number
JP2005522454A5
JP2005522454A5 JP2003568051A JP2003568051A JP2005522454A5 JP 2005522454 A5 JP2005522454 A5 JP 2005522454A5 JP 2003568051 A JP2003568051 A JP 2003568051A JP 2003568051 A JP2003568051 A JP 2003568051A JP 2005522454 A5 JP2005522454 A5 JP 2005522454A5
Authority
JP
Japan
Prior art keywords
administered
dosage
plasmid per
aerosolized solution
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003568051A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005522454A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/004522 external-priority patent/WO2003068936A2/en
Publication of JP2005522454A publication Critical patent/JP2005522454A/ja
Publication of JP2005522454A5 publication Critical patent/JP2005522454A5/ja
Withdrawn legal-status Critical Current

Links

JP2003568051A 2002-02-14 2003-02-14 ｐ５３遺伝子及び抗癌化合物のエアゾール送達による肺転移抑制 Withdrawn JP2005522454A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35686402P 2002-02-14 2002-02-14
PCT/US2003/004522 WO2003068936A2 (en) 2002-02-14 2003-02-14 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds

Publications (2)

Publication Number Publication Date
JP2005522454A JP2005522454A (ja) 2005-07-28
JP2005522454A5 true JP2005522454A5 (https=) 2006-03-23

Family

ID=27734695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003568051A Withdrawn JP2005522454A (ja) 2002-02-14 2003-02-14 ｐ５３遺伝子及び抗癌化合物のエアゾール送達による肺転移抑制

Country Status (6)

Country Link
US (1) US20040028616A1 (https=)
EP (1) EP1476199A2 (https=)
JP (1) JP2005522454A (https=)
AU (1) AU2003216283A1 (https=)
CA (1) CA2475928A1 (https=)
WO (1) WO2003068936A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
ES2368963B1 (es) * 2009-07-04 2012-10-10 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii Procedimiento de identificación de agentes terapéuticos contra el melanoma y uso de agente identificado.
CN102114000B (zh) * 2009-12-31 2013-08-21 复旦大学 一种载药的共输送脂质纳米递药系统
CN104163920B (zh) * 2014-07-14 2016-08-17 东华大学 一种易于dna结合的转染试剂的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US6248720B1 (en) * 1996-07-03 2001-06-19 Brown University Research Foundation Method for gene therapy using nucleic acid loaded polymeric microparticles
WO1997039135A1 (en) * 1996-04-17 1997-10-23 Board Of Regents, The University Of Texas System Enhanced expression of transgenes
US6090407A (en) * 1997-09-23 2000-07-18 Research Development Foundation Small particle liposome aerosols for delivery of anti-cancer drugs
US6333051B1 (en) * 1998-09-03 2001-12-25 Supratek Pharma, Inc. Nanogel networks and biological agent compositions thereof
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
US6774119B1 (en) * 1999-04-26 2004-08-10 Cedars-Sinai Medical Center Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
US6284720B1 (en) * 1999-09-03 2001-09-04 Vertec Biosolvents, Llc Environmentally friendly ink cleaning preparation
EP1242106A4 (en) * 1999-12-04 2008-08-27 Res Dev Foundation IMPROVING INHALATION THERAPY USING CARBON GAS

Similar Documents

Publication Publication Date Title
WO2003082853A8 (en) New compounds
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
MXPA03011972A (es) Arilaminas para tratamiento de condiciones asociadas con gsk-3.
WO2005117890A3 (en) Thienopyrimidines and thiazolopyrimidines for use in medicine
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
GEP20053673B (en) Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
JP2007514005A5 (https=)
WO2003053330A3 (en) Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3
WO2007081949A3 (en) Small-volume oral transmucosal dosage forms
WO2004110346A3 (en) Sustained release of antiinfectives
MY143368A (en) Pyrrazolo-pyrimidine derivatives
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
JP2020510085A5 (https=)
JP2007510699A5 (https=)
NO20023551L (no) Ibuprofen-inneholdende aktivt middel-preparat
JP2000159790A5 (https=)
JP2008516004A5 (https=)
WO2008116601A3 (en) Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
WO2002000166A3 (en) New compounds useful as antibacterial agents
JP2005522454A5 (https=)
JP2005516898A5 (https=)
WO2003032946A3 (en) Ph-sensitive liposomes for targeted drug delivery
WO2005065429A3 (en) Composition and method for treatment of hepatic encephalopathy
WO2006060681A3 (en) Pharmaceutical composition containing an anti-nucleating agent